The Audit Bureau reveals huge private contracts for medicines in two hospitals run by the Ministry of Health

shopping Huge amounts of medication Without any legal action, contracts are split to avoid public tenders and purchase of health products Aside from the principles of openness and transparency, Among other shortcomings. The Audit Bureau reveals the absence of established oversight Pharmaceutical expenditures for two hospitals in the autonomous cities of Ceuta and Melilla Managed by the National Institute of Health Administration (Ingesa), within the Ministry of Health, As detailed in the inspection report dated 27 November consulted by ABC.

Between 2022 and 2023, the period analyzed, “drug purchases took place in large quantities, Through direct orders from supplier companies, These are called “monthly orders”, with an average usage value of 91% per Melilla Regional Hospital (HCM) and 49% of the total hospital pharmacy supply Ceuta University Hospital (HUC)”, managed by an entity affiliated with the Ministry of Health, which has been able to manage it since November 2023 Monica Garcia (Adds). Without contracting, i.e. “by hand”, both hospitals They spent €26,950,239: 18,648,531 euros in the case of the Melilla Health Complex and 8,301,708 euros in the case of Ceuta, as specified in the report.

The highest volume of purchases was between 2022 and 2023 when the ministry was at its helm Pharmacist Jose Manuel Menones (PSOE), was carried out “without the use of award procedures set out in the Law on Public Sector Contracts (LCSP), and In violation of the principles of openness and transparencyNon-discrimination and equal treatment,” details the study, which emphasizes the gradual increase in spending on medicines in hospitals at the national level.

The Accounting Council requests the “cancellation” of drug purchases outside the legal process

The acquisitions were made from 269 companies and included 2,233 products with different therapeutic indications. Although “there are exclusive drugs, there are also other drugs that have a lower unit value, have an identical indication, and are offered in multiple brands,” so “Use of arbitration procedures is appropriate» Organization “based on cost-effectiveness criteria”.

The Accounting Board recommends “eliminating the practice of direct purchasing of pharmaceutical products, taking into account the requirements of the LCSP, and implementing adequate oversight, Supervision and analysis of hospital pharmacy holdings, In order to enhance efficiency, transparency and compatibility of bidders.

Notices from auditors

Previously, the last permanent financial audit report of General intervention of social security Regarding the recruitment of healthcare management in Melilla, 56% of expenses were incurred in 2021 «It was not adequately supported in the contractBut this is done through direct purchases from suppliers outside established procedures.

In addition, there are 5,339 applications corresponding to 257 articles, with an accumulated cost of more than €15,000, They divided themselves to make them pass Regarding simple contracts, “in violation” of the aforementioned law, according to the report.

The supervisory body says that “a lack of appropriate planning has led to repeated requests being processed outside the principles of publicity, transparency, non-discrimination and equal treatment that guide public procurement.” Turnover rate of products purchased directly each yearGenerally a little over a month, he adds, explaining “the misprogramming of calculating a relevant amount depending on the budget managed by each hospital.”